484 related articles for article (PubMed ID: 22742466)
1. [Pneumocystis jirovecii pneumonia in HIV-infected patients].
De Castro N; Scemla A; Gallien S; Molina JM
Rev Mal Respir; 2012 Jun; 29(6):793-802. PubMed ID: 22742466
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
Su YS; Lu JJ; Perng CL; Chang FY
J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis jirovecii Pneumonia in Human Immunodeficiency Virus Infection.
Siegel M; Masur H; Kovacs J
Semin Respir Crit Care Med; 2016 Apr; 37(2):243-56. PubMed ID: 26974301
[TBL] [Abstract][Full Text] [Related]
5. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis jirovecii pneumonia in Latin America. A public health problem?
Calderón EJ; de Armas Y; Panizo MM; Wissmann G
Expert Rev Anti Infect Ther; 2013 Jun; 11(6):565-70. PubMed ID: 23750728
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis infection in humans: diagnosis and treatment.
Calderón EJ; Gutiérrez-Rivero S; Durand-Joly I; Dei-Cas E
Expert Rev Anti Infect Ther; 2010 Jun; 8(6):683-701. PubMed ID: 20521896
[TBL] [Abstract][Full Text] [Related]
8. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia.
Tyagi AK; Mirdha BR; Luthra K; Guleria R; Mohan A; Singh UB; Samantaray JC; Dar L; Iyer VK; Chaudhry R
J Infect Dev Ctries; 2010 Nov; 4(11):761-6. PubMed ID: 21252456
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of Cryptococcal Fungemia and
Tatli Kiş T; Yildirim S; Biçmen C; Yücel N; Kirakli C
Curr HIV Res; 2023; 21(4):259-263. PubMed ID: 37877566
[TBL] [Abstract][Full Text] [Related]
10. [Pneumocystosis during HIV infection].
El Fane M; Sodqi M; Oulad Lahsen A; Chakib A; Marih L; Marhoum El Filali K
Rev Pneumol Clin; 2016 Aug; 72(4):248-54. PubMed ID: 27349824
[TBL] [Abstract][Full Text] [Related]
11. Acute psychosis related to use of trimethoprim/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: a multicentre, retrospective study.
Lee KY; Huang CH; Tang HJ; Yang CJ; Ko WC; Chen YH; Lee YC; Hung CC
J Antimicrob Chemother; 2012 Nov; 67(11):2749-54. PubMed ID: 22821870
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
Kato H; Samukawa S; Takahashi H; Nakajima H
J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
[TBL] [Abstract][Full Text] [Related]
13. Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole.
Fisk M; Sage EK; Edwards SG; Cartledge JD; Miller RF
Int J STD AIDS; 2009 Sep; 20(9):652-3. PubMed ID: 19710343
[TBL] [Abstract][Full Text] [Related]
14. [Pneumocystis jirovecii pneumonia-an opportunistic infection undergoing change].
Hitzenbichler F; Mohr A; Salzberger B
Internist (Berl); 2019 Jul; 60(7):669-677. PubMed ID: 31089770
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.
Esposito S; Bojanin J; Porta A; Cesati L; Gualtieri L; Principi N
Pediatr Infect Dis J; 2005 Dec; 24(12):1117-20. PubMed ID: 16371882
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin.
Chang HC; Yang WT; Chen TC
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8961-8964. PubMed ID: 30575940
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of pneumocystis jirovecii pneumonia].
Borde JP; Offensperger WB; de With K
Dtsch Med Wochenschr; 2011 Jul; 136(27):1426-30. PubMed ID: 21713721
[No Abstract] [Full Text] [Related]
19. Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients.
Kofteridis DP; Valachis A; Velegraki M; Antoniou M; Christofaki M; Vrentzos GE; Andrianaki AM; Samonis G
J Infect Chemother; 2014 Jul; 20(7):412-6. PubMed ID: 24767467
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
Alvarez-Martínez MJ; Miró JM; Valls ME; Mas J; de la Bellacasa JP; Sued O; Solé M; Rivas PV; de Lazzari E; Benito N; García F; Agustí C; Wilson PE; Gatell JM; Jiménez de Anta MT; Meshnick SR; Moreno A
Diagn Microbiol Infect Dis; 2010 Sep; 68(1):60-5. PubMed ID: 20727472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
